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Background: The ATP-binding cassette transporter B1 (ABCB1) gene codes for a membrane efflux pump localized
in epithelial cells. Together with other Permeability-glycoproteins in the small and large intestine, its product
represents a barrier against xenobiotics, bacterial toxins, drugs and other substances introduced with diet, including
carcinogens. The aim of this investigation was to verify the possible contribution of ABCB1 single nucleotide
polymorphisms (SNPs) to the genetic risk of colorectal cancer (CRC).
Results: DNA obtained from the peripheral blood of 98 CRC patients and 100 healthy controls was genotyped for
the three selected SNPs: 1236C > T (rs1128503), 2677G > T/A (rs2032582), and 3435C > T (rs1045642). Molecular
data were analyzed to asses allele and haplotype association with CRC.
No evidence of an association between ABCB1 alleles and CRC occurrence as a whole was found. However, ABCB1
showed either association with carcinoma of the sigmoid colon, and appeared able to influence the sex ratio
among CRC patients. These two effects seemed to act independently based on multivariate analysis. We showed
that ABCB1 polymorphisms were able to influence CRC susceptibility related to tumor localization and patient
gender.
Conclusions: We suggest that sensitivity to undetermined risk factors could depend on the genetic background of
ABCB1 locus, with a mechanism that also depends on patient gender.
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Colorectal cancer (CRC) is among the three leading
causes of mortality determined by malignancies in
humans worldwide and the second cause of death in
Europe [1,2]. Genetic susceptibility factors seem to
interact with environmental – in particular, diet-related
and smoking-related – factors to increase the risk of
CRC [3,4]. Over 50% of CRC etiology has been demon-
strated to be attributable to diet and lifestyle [5,6]. A
number of studies has recently been carried out to verify* Correspondence: marcella.martinelli@unibo.it
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unless otherwise stated.the interaction between specific nutrients (meat, fish,
fruit and vegetables, fibre, vitamins, alcohol) and sus-
ceptibility genes [7]. The intestinal epithelium is the key
point of interaction between substances introduced
through the diet and gene products involved in the hu-
man metabolism. The adenosine triphosphate-binding
cassette transporter sub-family B member 1, ABCB1
(also called multiple drug resistance 1 - MDR1) plays a
role in modulating this interaction. Expressed in the
gastrointestinal tract in particular, it creates a sort of
barrier aimed at regulating the uptake of metabolites
and drugs [8]. Toxic xenobiotics specifically are elimi-
nated by organs which have an excretory function like
the liver and kidneys.
The Permeability-glycoprotein (P-gp), coded by ABCB1
gene, belongs to a group of ATP-dependent efflux pumpsal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Patient and control group information
Cases Controls P value
Age 70 ± 13 68 ± 12 0.26
Gender Male 52 49 0.57
Female 46 51




Position Cecum 1 -
Ascending colon 33 -
Transverse colon 9 -
Descending colon 12 -
Sigmoid colon 20 -
Rectum 23 -
aNot Determined.
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http://www.jbiomedsci.com/content/21/1/89that selectively transport substances out of cells. The
transport of harmful substances is necessary to protect
cells from death [9]; however, in a mouse model, mdr1a
overexpression has been associated with apoptosis inhib-
ition and increased risk of cancer [10]. More generally, an
altered function of P-gp could create a perturbation of the
intra-extra cellular environment equilibrium that could
lead to an increased risk of internalization of DNA dam-
aging factors, or potential carcinogens, thereby modulat-
ing susceptibility to neoplasm transformation.
Common ABCB1 gene polymorphisms have been inves-
tigated by different authors because of their potential abil-
ity to modulate ABCB1-mediated transport. In particular,
the C3435T (rs1045642) variant, that was correlated with
altered ABCB1 expression and activity in an in vivo func-
tional study [11], was also found to be associated with an
increased risk of developing CRC in patients under the
age of 50 [12] and in older non-smokers [13]. In addition,
C3435T (rs1045642) and G-rs3789243-A variants have
been seen to be associated with a modulation of the risk
of CRC, in conjunction with consumption of red and
processed meat [14]. However, conflicting results have
been reported, probably due to the intragenic hetero-
geneity among investigated populations [15-17], and no
association with cancer susceptibility was found in a
meta-analysis considering 34 case–control studies, of
which 9 were CRC-control studies [17].
In order to evaluate the possible correlation between
ABCB1 polymorphisms and the risk of CRC in a sample
study of Italians, we performed a case control associ-
ation analysis with three SNPs mapping in this gene.
Methods
Sample study
A cohort of 98 unrelated Italian colorectal cancer pa-
tients was recruited by the Department of Medical and
Surgical Sciences of S. Orsola-Malpighi Polyclinic,
Bologna University. Diagnosis of colorectal cancer was con-
firmed by histopathologic examination. The control group
consisted of 100 unrelated healthy Italian volunteers match-
ing for gender and age with patient group. Patient infor-
mation is summarized in Table 1. DNA extraction from
peripheral whole blood, collected before primary surgery,
was performed using a GenElute™ Blood Genomic DNA
Kit (Sigma, Milan, Italy). The study was approved by the
ethical committee of Sant’Orsola-Malpighi General Hos-
pital and complied with the Helsinki Declaration’s Ethical
Principles for Medical Research Involving Human Subjects.
Written informed consent was obtained from all patients
and healthy control subjects before study entry.
Single nucleotide polymorphism genotyping
Three SNPs mapping respectively on exon 12 (1236C >T;
rs1128503), 21 (2677G >T/A; rs2032582), and 26 (3435C >T; rs1045642) of the ABCB1 gene were chosen, based on
literature data. The first and last polymorphisms consist in
synonymous variants, while the rs2032582 represents a
missense variant (Ala893Ser/Thr). Each polymorphism was
amplified by PCR using flanking primers, and the products
incubated with a restriction endonuclease, BsuRI, GsaI and
DpnII (CABRU, Milan, Italy) respectively. Details about
polymorphisms are summarized on the Additional file 1.
Fragments were separated by 10% native polyacrylamide
gel electrophoresis, subsequently stained with ethidium
bromide (see Additional file 2). To assess the accuracy
of the genotyping outputs, one third of randomly se-
lected samples were blindly tested by a second operator.Statistical analysis
Power calculation, given the actual sample size and con-
sidering the investigated polymorphisms as susceptibility
variations, indicated a power over 80% for genotypic
odds ratios higher than 2.5 [18]. The distribution of ge-
notypes in patient and control groups was tested for de-
viations from the Hardy–Weinberg equilibrium using
Pearson’s χ2 test. Genetic association was firstly investi-
gated using a likelihood ratio approach by Unphased
software v3.1.5 in a Windows Vista operative system
[19]. Odd ratios were calculated in order to estimate the
level of association of the rare allele carriers, i.e. hetero-
zygotes versus non-carriers, as well as homozygotes ver-
sus non-carriers.
Logistic regression was then used for multivariate ana-
lyses employing SPSS software in order to include available
clinical data. Regression modeling was adopted because it
did not require specific definition of the exposure and
confounder variables, since all explanatory variables
were treated in the same way.
Table 3 Genotyping information about SNP rs2032582
mapping on exon 21
Genotype
Na GG GT TT MAFb P value
Controls 100 32 44 24 0.46 ref. c
Cases 98 32 45 21 0.44 0.75
Cases Grade 1 5 2 1 2 0.5 1.00
Grade 2 65 20 31 14 0.45 0.91
Grade 3 21 8 8 5 0.43 0.71
Cases Colon 52 15 26 11 0.46 0.98
Sigmoid colon 22 12 8 2 0.27 0.023
Rectum 24 5 11 8 0.56 0.20
Controls Male 49 16 21 12 0.46 ref.
Cases Male 52 20 26 6 0.37 0.18
Controls Female 51 16 23 12 0.46 ref.
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using the Haploview program. Since linkage disequilib-
rium was evident, haplotype association analysis was
adopted to further investigate any evidence of genetic as-
sociation with single SNP obtained in the investigation.
The haplotype association analysis was performed with
the aid of Unphased software. A specific test for each
haplotype was carried out. This test is a score test for a
difference in risk between one haplotype and all the
others pooled together. This is in contrast with the odds
ratios, which were calculated in relation to a single refer-
ence haplotype. A permutation test was performed with
10,000 sample replicates, to allow for multiple testing
corrections over all the tests done. In each replicate the
trait values were randomly shuffled between all subjects.
Results
Bivariate analysis
Only 3 genotypes were missing in the genotyping step
(call rate > 99%). Genotype frequencies among both cases
and controls satisfied the Hardy-Weinberg equilibrium.
An association study was performed to test if genetic vari-
ants in ABCB1 were associated with CRC as whole or with
any of the subgroups identified according to histological
grade, tumor localization (cecum, ascending, transverse
and descending colon cancers were pooled and indicated
in the table as colon) and patient gender (Tables 2, 3, and
4). Variant alleles appeared not to be associated with the
occurrence of CRC nor with histological grade; however, a
significant association was observed with carcinoma of the
sigmoid colon, and with CRC in the male strata. Indeed
the variant alleles of the rs1128503 and rs2032582 wereTable 2 Genotyping information about SNP rs1128503
mapping on exon 12
Genotype
Na CC CT TT MAFb P value
Controls 100 33 45 22 0.44 ref.c
Cases 96 37 38 21 0.42 0.57
Cases Grade 1 5 2 1 2 0.5 0.76
Grade 2 64 24 27 13 0.41 0.58
Grade 3 20 8 7 5 0.43 0.82
Cases Colon 51 19 21 11 0.42 0.70
Sigmoid colon 21 14 5 2 0.21 0.0056
Rectum 24 4 12 8 0.58 0.085
Controls Male 49 14 24 11 0.47 ref.
Cases Male 52 25 21 6 0.32 0.027
Controls Female 51 19 21 11 0.42 ref.
Cases Female 44 12 17 15 0.53 0.12
aNumber of individuals.
bMinor Allele Frequency.
creference.less frequent in patients with a tumor localized in the sig-
moid colon (P value 0.006 and 0.023, respectively). The
calculated odds ratio (OR) for rs1128503 variant allele het-
erozygote carriers versus non-carriers (ORhet) was 0.26
(95% C.I. 0.09–0.80), while for homozygote carriers versus
non-carriers (ORhom) it was 0.21 (95% C.I. 0.04–1.03). The
level of association with rs2032582 appears weaker; the
calculated ORs were ORhet = 0.49 (95% C.I. 0.18–1.32) and
ORhom = 0.22 (95% C.I. 0.05–1.09). Stratification by gender
showed that rs1128503 was associated to CRC occurrenceTable 4 Genotyping information about SNP rs1045642
mapping on exon 26
Genotype
Na CC CT TT MAFb P value
Controls 100 29 42 29 0.5 ref. c
Cases 97 28 45 24 0.48 0.68
Cases Grade 1 5 2 1 2 0.5 1.00
Grade 2 64 17 29 18 0.51 0.89
Grade 3 21 8 10 3 0.38 0.16
Cases Colon 51 14 27 10 0.46 0.52
Sigmoid colon 22 8 7 7 0.48 0.78
Rectum 24 6 11 7 0.52 0.79
Controls Male 49 13 20 16 0.53 ref.
Cases Male 51 17 26 8 0.41 0.092
Controls Female 51 16 22 13 0.47 ref.
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ORhom = 0.31 (95% C.I. 0.09–1.00)). The variant allele, that
was less frequent in male patients (MAF = 0.32) with re-
spect to controls (MAF = 0.44), was more frequent in fe-
male patients (MAF = 0.53); but the difference with respect
to female controls was not significant (P = 0.12). No differ-
ence in allelic frequency was observed between genders
within the control group.
Multivariate analyses
Since bivariate statistics suggested that ABCB1 polymor-
phisms could influence localization of cancer and could
act differently in the two genders, a multivariate statis-
tics approach was adopted to understand how ABCB1
genotype was able to influence CRC localization and sex
ratio among CRC patients, considering additional poten-
tially confounding factors. First of all, logistic regression
was used to see if the outcome (0 = healthy controls, 1 =
CRCs in a specific position, i.e. colon, or sigma, or rec-
tum) could be predicted according to rs1128503 geno-
type and gender (Table 5). This analysis indicated that
carcinoma of the sigmoid colon is associated with
rs1128503 and that the gender did not act as a con-
founding factor. Indeed, the ORs for variant allele car-
riers compared to non-carriers, corrected for gender,
were almost unchanged in relation with crude ORs ob-
tained in the bivariate analysis.
The second multivariate analysis was aimed at testing
if sex ratio among patients (0 = CRC male patients, 1 =
CRC female patients) could be predicted according to
tumour position (colon, sigma, rectum), histological grade
(G1, G2, G3), age of diagnosis (years), and rs1128503
genotype (Table 6). Among these independent variables,
the factor which influenced the sex ratio most strongly
was the rs1128503 genotype (P = 0.009). The ORs of fe-
male CRC patients with rs1128503 variant allele, versus
non-carriers, corrected for all the other factors were
ORhet = 0.11 (95% C.I. 0.03–0.44), ORhom = 0.24 (95% C.I.
0.06–0.87). In addition, a borderline effect was observed
for histological grade (P = 0.07), where the OR of femalesTable 5 Logistic regression analysis to test if sigmoid colon c
modeled by rs1128503 genotype and gender
Independent variable Ba s.e.b
rs1128503
CT vs CC -1.35 0.57
TT vs CC -1.53 0.81
Gender (0 = male, 1 = female) -0.33 0.50
Constant -0.70 0.39




ddegrees of freedom.with a G3 tumor, versus G1 tumor, corrected for all the
other factors was 0.26 (95% C.I. 0.08–0.87).
Haplotype association analysis
To further investigate genetic association between
ABCB1 and cancer of the sigmoid colon, a haplotype as-
sociation analysis was performed (Table 7). Some haplo-
types showed higher association than alleles, suggesting
that the actual susceptibility polymorphism was not
typed. The higher association level was observed for the
haplotype rs1128503C- rs2032582G- rs1045642T (P
value = 0.0007). This haplotype is more frequent among
sigmoid colon cancer patients; the odds ratio with re-
spect to the most frequent haplotype was 3.48 (95% C.I.
1.23–9.82). Since several tests were performed in this
analysis, a permutation test was conducted to adjust sig-
nificance levels: the corrected P value for rs1128503C-
rs2032582G- rs1045642T association was 0.032.
Gender specific haplotype occurrence was evaluated
among CRC patients. A significant difference between
male CRC and female CRC was evident for each of the
tested alleles as well as for some of the haplotypes; nom-
inal P values and ORs are shown in Table 8. After multiple
comparison correction, males confirmed a significantly
higher frequency of the common allele of the rs1128503
polymorphism (corrected P value = 0.035), as well as
of the haplotype rs1128503C-rs2032582G (corrected P
value = 0.047).
Discussion
The major function of the ABCB1 product is to extrude a
range of different toxic xenobiotic compounds from cells,
thus protecting the organism against potentially harmful
exposure. ABCB1, as well as other P-glycoproteins, con-
fers protection by limiting xenobiotic absorption along the
gastrointestinal tract, and stimulating excretion of these
compounds by the liver and kidneys [20,21]. The activity
of this efflux pump may be influenced, in part, by the
expression levels of the ABCB1 gene. At present, at least
one polymorphism, the C3435T mapping in exon 26ancer (0 = healthy controls, 1 = sigmoid colon) can be
Waldc d.f.d P value OR (95% C.I.)
7.57 2 0.02
5.58 1 0.02 0.26 (0.08–0.79)
3.60 1 0.06 0.22 (0.04–1.05)
0.44 1 0.51 0.72 (0.27–1.92)
3.17 1 0.07
Table 6 Logistic regression analysis to test if sex ratio among patients (0 = male patients, 1 = female patients) can be
modeled by rs1128503 genotype, histological grade, tumor localization, and age of diagnosis
Independent variable Ba s.e.b Waldc d.f.d P value OR (95% C.I.)
rs1128503 9.52 2.00 0.01
CT vs CC -2.22 0.72 9.51 1.00 0.00 0.11 (0.03–0.45)
TT vs CC -1.45 0.67 4.67 1.00 0.03 0.24 (0.06–0.87)
Grade 5.27 2.00 0.07
G2 vs G1 -1.91 1.23 2.42 1.00 0.12 0.15 (0.01–1.65)
G3 vs G1 -1.33 0.61 4.75 1.00 0.03 0.26 (0.08–0.87)
Localization 1.18 2.00 0.55
sigma vs colon 0.61 0.61 1.02 1.00 0.31 1.85 (0.56–6.08)
rectum vs colon 0.68 0.75 0.83 1.00 0.36 1.98 (0.46–8.57)
Age -0.01 0.02 0.23 1.00 0.63
Constant 2.54 1.63 2.43 1.00 0.12





Table 7 Allele and haplotype association analysis for sigmoid colon cancer
M1a M2b M3c Case Control Case-Freq Control-Freq OR (95% C.I.) Chisq P value
C - - 33.0 111.0 0.79 0.56 ref.d
T - - 9.0 89.0 0.21 0.45 0.34 (0.15–0.75) 7.668 0.0056
- G - 32.0 108.0 0.73 0.54 ref.
- T - 12.0 92.0 0.27 0.46 0.44 (0.21–0.90) 5.172 0.023
- - C 23.0 100.0 0.52 0.50 ref.
- - T 21.0 100.0 0.48 0.50 0.91 (0.48–0.76) 0.075 0.78
C G - 30.0 97.4 0.71 0.49 ref. 7.104 0.0077
C T - 3.0 13.6 0.07 0.07 0.72 (0.19–2.68) 0.018 0.89
T G - 0.0 10.6 0.00 0.05 not calculable 2.237 0.13
T T - 9.0 78.4 0.21 0.39 0.37 (0.16–0.83) 4.916 0.027
C - C 22.0 91.0 0.52 0.48 ref. 0.277 0.60
C - T 11.0 16.0 0.26 0.08 2.84 (1.16–6.98) 10.560 0.0012
T - T 9.0 83.0 0.21 0.44 0.45 (0.20–1.03) 7.120 0.0076
- G C 21.9 90.3 0.50 0.45 ref. 0.328 0.57
- G T 10.1 17.7 0.23 0.09 2.37 (0.94–5.92) 7.129 0.0076
- T C 1.1 9.7 0.03 0.05 0.49 (0.06–4.09) 0.539 0.46
- T T 10.9 82.3 0.25 0.41 0.55 (0.25–1.20) 4.085 0.043
C G C 21.0 83.2 0.50 0.44 ref. 0.540 0.46
C G T 9.0 10.3 0.21 0.05 3.48 (1.23–9.82) 11.390 0.00074
C T C 1.0 7.8 0.02 0.04 0.51 (0.06–4.37) 0.289 0.59
C T T 2.0 5.7 0.05 0.03 1.38 (0.25–7.65) 0.488 0.49
T G T 0.0 7.6 0.00 0.04 not calculable 1.596 0.21
T T T 9.0 75.5 0.21 0.40 0.47 (0.20–1.10) 5.173 0.023
aM1 1236 C > T rs1128503.
bM2 2677 G > T/A rs2032582.
cM3 3435 C > T rs1045642.
dreference.
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Table 8 CRC male (case) versus CRC female (control) allele and haplotype association analysis
M1a M2b M3c Male Female Male-Freq Fem-Freq OR (95% C.I.) Chisq P value
C - - 71 41 0.68 0.47 ref.d - -
T - - 33 47 0.32 0.53 0.40 (0.23–0.73) 9.22 0.0024
- G - 66 43 0.63 0.47 ref. - -
- T - 38 49 0.37 0.53 0.50 (0.29–0.90) 5.53 0.019
- - C 60 41 0.59 0.45 ref. - -
- - T 42 51 0.41 0.55 0.56 (0.32–0.99) 3.94 0.047
C G - 63.8 34.7 0.61 0.39 ref. 9.09 0.003
C T - 7.2 6.3 0.07 0.07 0.61 (0.19–1.99) 0.00 0.99
T G - 2.2 5.3 0.02 0.06 0.22 (0.04–1.21) 1.88 0.17
T T - 30.8 41.7 0.30 0.47 0.4 (0.22–0.75) 6.61 0.010
C - C 52.5 27.9 0.52 0.32 ref. 7.68 0.0056
C - T 17.5 13.2 0.17 0.15 0.70 (0.28–1.75) 0.26 0.61
T - C 7.5 11.2 0.07 0.13 0.35 (0.11–1.13) 1.49 0.22
T - T 24.5 35.9 0.24 0.41 0.36 (0.18–0.72) 6.78 0.009
- G C 51.8 33.4 0.51 0.36 ref. 4.41 0.036
- G T 13.2 9.6 0.13 0.10 0.89 (0.33–2.39) 0.26 0.61
- T C 8.2 7.6 0.08 0.08 0.70 (0.22–2.23) 0.02 0.90
- T T 28.8 41.4 0.28 0.45 0.45 (0.24–0.86) 5.90 0.015
C G C 49.0 27.4 0.50 0.32 ref. 6.35 0.012
C G T 12.9 7.4 0.13 0.09 0.97 (0.34–2.81) 0.99 0.32
C T T 4.1 6.2 0.04 0.07 0.37 (0.10–1.45) 0.71 0.40
T G C 2.1 3.2 0.02 0.04 0.37 (0.06–2.39) 0.33 0.57
T T C 5.9 7.4 0.06 0.09 0.44 (0.13–1.58) 0.55 0.46
T T T 24.0 34.4 0.24 0.40 0.39 (0.19–0.79) 5.33 0.021
aM1 1236 C > T rs1128503.
bM2 2677 G > T/A rs2032582.
cM3 3435 C > T rs1045642.
dreference.
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amount of final product of the gene [11,22]. This poly-
morphism has been suspected to play a role in the de-
velopment of different kinds of cancer such as glioma,
breast cancer and renal epithelial tumors [17,23,24], in
addition, of course, to colon cancer [12,25].
Our investigations indicate that ABCB1 has a role in
CRC, particularly in the onset of carcinoma localized in
the sigmoid colon. Indeed, the variant allele at rs1128503
and rs2032582 was less frequent in patients with tumors
of the sigmoid colon. Since some haplotypes showed a
stronger association than the alleles, we could speculate
that the allele which is truly responsible has not yet been
typed. Association between ABCB1 haplotypes and CRC
was described in a Polish population suggesting a prog-
nostic role in less advanced CRC, for the same genetic
markers investigated in the present work [26,27].
In addition, the present investigation showed that
polymorphisms of ABCB1 were differentially represented
in males and females. It should be pointed out that theincidence rate of colon cancer differs significantly ac-
cording to gender (male: female = 2: 1). Gender may re-
flect the different influence levels of exposure to risk
factors, related to occupational exposures, diet, or life-
style; but the level of susceptibility to a particular risk
factor could also be gender specific. For example, Da-
nish homozygote carriers for the C3435T polymorphism
showed an increased risk of developing CRC in relation
to their red meat consumption [14]. Hormonal levels
can also influence gene expression. It is known, for ex-
ample, that steroid hormones such as progesterone
modulate P-gp expression in some tissues, as evidenced
in a murine model [28-30].
In the present investigation we found that SNPs in
ABCB1 can influence susceptibility to CRC, but with
gender related specificity. In fact, ancestral alleles were
more frequently found in CRC males, while variant al-
leles were more represented in females, even when
haplotype occurrence was considered. Allele frequency
in controls was similar in the two genders and at
Martinelli et al. Journal of Biomedical Science 2014, 21:89 Page 7 of 8
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SNPs may either alter ABCB1 expression by influencing
regulatory sequences that are the target of steroid hor-
mones, or may alter ABCB1 ability to process specific
substances whose intake could be influenced by gender.
This could indicate that SNPs in ABCB1 are able to in-
fluence CRC susceptibility, but with a mechanism that
could be gender-related. A similar hypothesis could be
endorsed by Nakamura and colleagues’ findings [31],
which suggested that serum levels of cortisol and aldos-
terone can be influenced by the common ABCB1
rs1045642 polymorphism in women.
Conclusions
Based on our results we could speculate that, even if
hormones like progesterone are not transported by P-gp
[29], they could in any case modulate the efficiency of
the efflux pump, determining the gender variability ob-
served in our sample study.
In addition, we suggest that some of the differences in
colon cancer incidence in male and female patients may
be due to gender-dependent differences in ABCB1 hormo-
nal modulation determining a different role of the same
polymorphism. Our data, even if related to different
markers howbeit mapping on the same gene, are in accord
with those reported by Sainz and colleagues [32]. They too
evidenced a different level of CRC risk in patients carrying
a specific ABCB1 SNP variant, depending on gender.
However, given the complexity both of the mechanisms
involved in CRC development and of the hormone-
mediated effects, a more comprehensive investigation
employing bigger sample studies is required to fully ad-
dress the real role of ABCB1 polymorphisms in CRC.
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